These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 19176460)
1. Searching for less toxic larynx preservation: a need for common definitions and metrics. Forastiere AA; Trotti AM J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460 [No Abstract] [Full Text] [Related]
2. [Induction chemotherapy and larynx preservation: is such practice useful?]. Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041 [TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583 [TBL] [Abstract][Full Text] [Related]
4. Larynx preservation and survival trends: should there be concern? Forastiere AA Head Neck; 2010 Jan; 32(1):14-7. PubMed ID: 19953631 [No Abstract] [Full Text] [Related]
5. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma. Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227 [TBL] [Abstract][Full Text] [Related]
6. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276 [TBL] [Abstract][Full Text] [Related]
7. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. Pointreau Y; Garaud P; Chapet S; Sire C; Tuchais C; Tortochaux J; Faivre S; Guerrif S; Alfonsi M; Calais G J Natl Cancer Inst; 2009 Apr; 101(7):498-506. PubMed ID: 19318632 [TBL] [Abstract][Full Text] [Related]
10. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998 [TBL] [Abstract][Full Text] [Related]
11. [Current role for induction chemotherapy in head and neck tumors]. Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986 [TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968 [TBL] [Abstract][Full Text] [Related]
14. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy. Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429 [TBL] [Abstract][Full Text] [Related]
15. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer. Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955 [TBL] [Abstract][Full Text] [Related]
16. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma]. de Crevoisier R; Mazeron JJ Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570 [No Abstract] [Full Text] [Related]
17. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Posner MR; Norris CM; Wirth LJ; Shin DM; Cullen KJ; Winquist EW; Blajman CR; Mickiewicz EA; Frenette GP; Plinar LF; Cohen RB; Steinbrenner LM; Freue JM; Gorbunova VA; Tjulandin SA; Raez LE; Adkins DR; Tishler RB; Roessner MR; Haddad RI; Ann Oncol; 2009 May; 20(5):921-7. PubMed ID: 19179556 [TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect? Pfister DG; Ridge JA J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409 [No Abstract] [Full Text] [Related]
19. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. Lefebvre JL; Chevalier D; Luboinski B; Kirkpatrick A; Collette L; Sahmoud T J Natl Cancer Inst; 1996 Jul; 88(13):890-9. PubMed ID: 8656441 [TBL] [Abstract][Full Text] [Related]
20. Approaches to preserve larynx function in locally advanced laryngeal and hypopharyngeal cancer. Rudat V; Pfreundner L; Hoppe F; Dietz A Onkologie; 2004 Aug; 27(4):368-75. PubMed ID: 15347892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]